Accelerate Diagnostics Inc
AXDX0.034USD
0.000
Close 11/25, 16:00（ET）Quotes delayed by 15 min
856.34KMarket Cap
LossP/E TTM
Accelerate Diagnostics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
11.70M
-2.99%
EPS(YoY)
-2.15
56.51%
Analyst Rating
2025-05-21
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its total revenue reached 11.70M, with a year-on-year change of -2.99%.
What is the Earnings Per Share (EPS) of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.148, with a year-on-year change of 56.51%.
What is the net income of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its net income was -50.05M, with a year-on-year change of 18.78%.
What is the net margin of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its net profit margin was -427.81%, with a year-on-year change of 16.28%.
What is the gross margin of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its gross margin was 23.12%, with a year-on-year change of -25.35%.
What is the debt-to-asset ratio of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its debt-to-asset ratio was 222.28%, with a year-on-year change of 85.06%.
What is the Return on Equity (ROE) of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its Return on Assets (ROA) was -167.03%, with a year-on-year change of -30.63%.
What is the operating profit of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its operating profit was -35.31M, with a year-on-year change of 33.18%.
What are the current assets of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its current assets were 22.24M, with a year-on-year change of -9.11%.
What are the total assets of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its total assets of Accelerate Diagnostics Inc were 28.56M, with a year-on-year change of -8.96%.
What are the total liabilities of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its total liabilities of Accelerate Diagnostics Inc were 84.60M, with a year-on-year change of 65.05%.
What is the total equity of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its total equity of Accelerate Diagnostics Inc was -56.04M, with a year-on-year change of -181.78%.
What is the net operating income of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its net operating income of Accelerate Diagnostics Inc was -50.05M, with a year-on-year change of 18.78%.
What is the net investment of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its net investment of Accelerate Diagnostics Inc was -509.00K, with a year-on-year change of -105.88%.
What is the net financing of Accelerate Diagnostics Inc?
According to Accelerate Diagnostics Inc's FY2024 earnings report, its net financing of Accelerate Diagnostics Inc was 27.05M, with a year-on-year change of 199.96%.
